Recruiting OBSERVATIONAL NCT06348693

Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness

Strategies for the Development of Multimodal Therapies in Tumors of the Central Nervous System: Identification of New Molecular and Metabolic Targets Implicated in Survival and Chemoresistance Involving Endothelial and Cancer Stem Cells

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions Glioblastoma Glioma Glioma Glioblastoma Multiforme

Interventions cell isolation from tumor biopsies and biomarker investigation

Updated 3 times since 2024 Last updated: Mar 29, 2024 Started: Apr 19, 2017 Primary completion: Nov 21, 2025 Completion: Nov 21, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Glioblastoma and Glioma and is currently actively recruiting participants. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico leads this study, which shows 3 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Data source: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy